# Biomarkers for Diagnosis of Lung Cancer

> **NCT02050100** · — · COMPLETED · sponsor: **SK Medical (Beijing) Co., Ltd.** · enrollment: 300 (actual)

## Conditions studied

- Lung Cancer
- Lung Neoplasm

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02050100
- **Lead sponsor:** SK Medical (Beijing) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-10
- **Final completion:** 2015-05
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2017-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02050100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02050100, "Biomarkers for Diagnosis of Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02050100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*